Nura Bio
PrivateLast Round
Series B
Jun 22, 2026
Total Funding Raised
$214.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nura Bio is a biotechnology company that develops neuroprotective therapies aimed at preventing neuronal loss and enhancing immune function in the nervous system following neurological injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nura Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nura Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 22, 2026 | ||||
| Series A Extension | Sep 17, 2024 | ||||
| Series A | Jul 29, 2020 |
Key People
Founding team and executive leadership
Nura Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A, Series B, Series A Extension |
| The Chernin Group | Series A, Series A Extension |
| Sanofi Ventures | Series B, Series A Extension |
| Samsara BioCapital | Series A, Series B, Series A Extension |
| Euclidean Capital | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$74M round led by The Column Group.
- Feb 18, 2025
Lahar Mehta, SVP Global Clinical Development, departed.
Nura Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nura Bio's valuation, stock price, and market status.